AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor

NCT00719524 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: OMBRABULIN (AVE8062)

Sponsor

Sanofi